← Back to Search

Cases with Air Trapping for Chronic Obstructive Pulmonary Disease

N/A
Waitlist Available
Led By Ganesh Krishna, MD
Research Sponsored by Respira Labs, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

Summary

This is a pilot observational study during which the investigators will conduct a longitudinal assessment of air trapping (with up to 2 visits) in 40 patients with COPD and variable degrees of air trapping and 20 healthy controls using ARIA. The investigators will characterize the clinical phenotype of the subjects by administering health and symptom-based questionnaires and obtaining lung function testing at rest and during exertion, and will then correlate and validate the ARIA-based indices with those of the more traditional physiologic measures of static and dynamic air trapping.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change and variability fo acoustic resonance
Correlation between acoustic resonance measurements with clinical testing
Secondary study objectives
Acoustic Stimulation
Data quality and user experience with medical-grade adhesive

Trial Design

3Treatment groups
Experimental Treatment
Group I: Healthy ControlsExperimental Treatment1 Intervention
Non COPD patients and non-smokers
Group II: Cases without Air TrappingExperimental Treatment1 Intervention
20 COPD patients without lung volumes representing air trapping (RV/TLC and functional residual capacity to TLC \[FRC/TLC\])
Group III: Cases with Air TrappingExperimental Treatment1 Intervention
20 COPD patients with lung volumes representing air trapping (RV/TLC and functional residual capacity to TLC \[FRC/TLC\])

Find a Location

Who is running the clinical trial?

Palo Alto Medial FoundationUNKNOWN
El Camino HealthUNKNOWN
Respira Labs, IncLead Sponsor
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top